Literature DB >> 15964964

Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels.

Danielle V Clark1, Mammen P Mammen, Ananda Nisalak, Virat Puthimethee, Timothy P Endy.   

Abstract

Dengue fever and dengue hemorrhagic fever constitute a substantial health burden on the population in Thailand. In this study, the impact of symptomatic dengue virus infection on the families of patients hospitalized at the Kamphaeng Phet Provincial Hospital with laboratory-confirmed dengue in 2001 was assessed, and the disability-adjusted life years (DALYs) lost for fatal and non-fatal cases of dengue were calculated using population level data for Thailand. When we accounted for the direct cost of hospitalization, indirect costs due to loss of productivity, and the average number of persons infected per family, we observed a financial loss of approximately US$61 per family, which is more than the average monthly income in Thailand. The DALYs were calculated using select results from a family level survey, and resulted in an estimated 427 DALYs/million population in 2001. This figure is of the same order of magnitude as the impact of several diseases currently given priority in southeast Asia, such as the tropical cluster (trypanosomiasis, Chagas disease, schistosomiasis, leishmaniasis, lymphatic filariasis, and onchocerciasis), malaria, meningitis, and hepatitis. These results indicate that dengue prevention, control, and research should be considered equally important as that of diseases currently given priority.

Entities:  

Mesh:

Year:  2005        PMID: 15964964

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  52 in total

1.  The necessity and quandaries of dengue vaccine development.

Authors:  Stephen J Thomas
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

2.  Dengue in Costa Rica: the gap in local scientific research.

Authors:  Adriana Troyo; Sherri L Porcelain; Olger Calderón-Arguedas; Dave D Chadee; John C Beier
Journal:  Rev Panam Salud Publica       Date:  2006-11

3.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

Review 4.  Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.

Authors:  James A Potts; Alan L Rothman
Journal:  Trop Med Int Health       Date:  2008-09-16       Impact factor: 2.622

5.  Climate variability and dengue fever in warm and humid Mexico.

Authors:  Felipe J Colón-González; Iain R Lake; Graham Bentham
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

Review 6.  Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey.

Authors:  Dagna Constenla; Cristina Garcia; Noah Lefcourt
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

Review 7.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

8.  Cost and disease burden of dengue in Cambodia.

Authors:  Julien Beauté; Sirenda Vong
Journal:  BMC Public Health       Date:  2010-08-31       Impact factor: 3.295

9.  Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators.

Authors:  James A Potts; Robert V Gibbons; Alan L Rothman; Anon Srikiatkhachorn; Stephen J Thomas; Pra-On Supradish; Stephenie C Lemon; Daniel H Libraty; Sharone Green; Siripen Kalayanarooj
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

10.  Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.

Authors:  Anna P Durbin; Sandra V Mayer; Shannan L Rossi; Irma Y Amaya-Larios; Jose Ramos-Castaneda; Eng Eong Ooi; M Jane Cardosa; Jorge L Munoz-Jordan; Robert B Tesh; William B Messer; Scott C Weaver; Nikos Vasilakis
Journal:  Virology       Date:  2013-02-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.